Drug intelligence / Profile preview

Adwin Plus

Development stage
Unknown
Lead developer
Thrift Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Adwin Plus is an oral combination drug developed and marketed by Thrift Pharmaceuticals. It contains two active ingredients: paracetamol (acetaminophen), a widely used analgesic and antipyretic, and domperidone, a dopamine receptor antagonist that acts as an antiemetic and prokinetic agent. This combination is formulated as oral tablets and a paediatric oral suspension, and is typically used to treat pain and fever accompanied by nausea or vomiting. Paracetamol works by inhibiting prostaglandin synthesis in the central nervous system to alleviate pain and reduce fever, while domperidone blocks peripheral dopamine receptors in the chemoreceptor trigger zone and gastrointestinal tract to prevent nausea and vomiting and facilitate gastric emptying.

Brand names
ADWIN-PLUSAdwin Plus
Other names
acetaminophen + domperidonedomperidone + acetaminophendomperidone + paracetamolparacetamol + domperidone
02

Targets

DRD2 (Dopamine D2 Receptor)DRD3 (Dopamine receptor D3)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Adwin Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adwin Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call